OpGen Inc. Logo

OpGen Inc. (OPGN)

OTC

Currency in USD
3.99
+0.03 (+0.71%)

Closed

Oct 9, 2026

Day's Range

3.85
4.00

52 wk Range

0.000100
34.00

Overview - OPGN - OpGen Inc.

Key Statistics

Valuation

Enterprise Value

152.54M

P/E (Trailing)

‪137.50‬

P/E (Forward)

‪-85.34‬

PEG Ratio

‪-1.00‬

Price / Sales (TTM)

‪27.91‬

Price / Book

‪24.52‬

EV / EBITDA

‪22.30‬

Profitability

Profit Margin

‪76.03%‬

Operating Margin

‪73.93%‬

Return on Assets

‪45.93%‬

Return on Equity

‪104.12%‬

Ownership

Shares Outstanding

10.07M

Float

3.15M

Short % of Shares Outstanding

‪1.79%‬

Held by Insiders

‪72.56%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪-3,052.63‬

50-Day Avg

‪22.24‬

200-Day Avg

‪8.61‬

Dividends

Payout Ratio

‪0.00%‬

Latest News - OPGN - OpGen Inc.

News & Analysis

View all news

Market Cap - OPGN - OpGen Inc.

Peers - OPGN - OpGen Inc.

Peer Comparison

Compared with companies in Capital Markets listed on OTC.

Profile Summary - OPGN - OpGen Inc.

About

OpGen Inc. is a biotechnology company that focuses on developing molecular diagnostics and bioinformatics solutions aimed at combating infectious diseases. The company's core purpose is to provide innovative diagnostic products and services that enable rapid identification and treatment guidance for a variety of…

SectorFinancial Services
IndustryCapital Markets
Employees1
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.